High-Dimensional Pharmaceuticals closes Pre-A round, nears hundreds of millions for the year
What's the deal? High-Dimensional PharmaceuticalsDealroom has a profile for this one. Try Dealroom →, a Hangzhou-based drug developer, has closed a Pre-A funding round, announced on October 14. The company says its cumulative financing this year now reaches hundreds of millions of yuan.
Who's backing it? Huatai Genscript Fund and Dongfang Jiafu co-led the round. Guofang CapitalDealroom has a profile for this one. Try Dealroom →, Ruili Investment, and Chuchang Fund joined as new investors.
Why it matters: Existing backers Xinghua DingliDealroom has a profile for this one. Try Dealroom →, Xihu Innovation, and GF Xinde all added to their stakes. Repeat participation from prior investors signals continued confidence from those closest to the company.
The signal: The breadth of named institutions — spanning state-linked and private capital — points to a crowded, competitive field of backers seeking footholds in China's biopharma sector.
Read more: sohu.com
Image credit: zhouxuan12345678
